Literature DB >> 10890673

Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase.

M W Quasney1, K Orman, J Thompson, J C Ring, M Salim, R A Schoumacher, D Watson, W Novick, S R Deitcher, R Joyner.   

Abstract

OBJECTIVE: To describe the use of aerosolized urokinase in a patient with plastic bronchitis after a Fontan procedure.
DESIGN: Case report.
SETTING: Pediatric intensive care unit in a university-affiliated children's hospital. PATIENTS: Report of one patient with acute respiratory failure secondary to plastic bronchitis.
INTERVENTIONS: Aerosolized urokinase, multiple bronchoscopies, corticosteroids, mucolytics, bronchodilators, and atrial pacing.
MEASUREMENTS AND MAIN RESULTS: Airway obstruction secondary to recurring casts improved with the treatments. Histologic analysis of the casts demonstrated less fibrin after treatments with aerosolized urokinase. No adverse events were noted.
CONCLUSIONS: The addition of aerosolized urokinase to this patient's treatment regimen helped to resolve life-threatening airway obstruction secondary to fibrin casts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10890673     DOI: 10.1097/00003246-200006000-00074

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  A case of plastic bronchitis presenting 9 years after Fontan.

Authors:  H J Zaccagni; L Kirchner; J Brownlee; K Bloom
Journal:  Pediatr Cardiol       Date:  2007-10-11       Impact factor: 1.655

Review 2.  Successful management of plastic bronchitis in a child post Fontan: case report and literature review.

Authors:  Paul Do; Inderpal Randhawa; Terry Chin; Kourosh Parsapour; Eliezer Nussbaum
Journal:  Lung       Date:  2012-03-20       Impact factor: 2.584

3.  Fenestration of the Fontan circuit as treatment for plastic bronchitis.

Authors:  J Wilson; J Russell; W Williams; L Benson
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

4.  Plastic bronchitis developing 5 years after Fontan procedure in a girl with Kartagener's syndrome.

Authors:  Tomohiro Nawa; Masato Yokozawa; Motoki Takamuro; Ai Kasuga
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

Review 5.  The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.

Authors:  Ganesh K Gnanappa; David S Celermajer; Gary F Sholler; Tom Gentles; David Winlaw; Yves d'Udekem; Julian Ayer
Journal:  Pediatr Cardiol       Date:  2016-10-27       Impact factor: 1.655

6.  Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator.

Authors:  Lauren Heath; Shelley Ling; Jennifer Racz; Gerta Mane; Lindsay Schmidt; Jeffrey L Myers; Wan C Tsai; Regine L Caruthers; Jennifer C Hirsch; Kathleen A Stringer
Journal:  Pediatr Cardiol       Date:  2011-07-24       Impact factor: 1.655

7.  Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.

Authors:  Kristina Brooks; Regine L Caruthers; Kurt R Schumacher; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2013-05-17       Impact factor: 4.705

8.  Evaluating failing Fontans for heart transplantation: predictors of death.

Authors:  Eric R Griffiths; Aditya K Kaza; Moritz C Wyler von Ballmoos; Hugo Loyola; Anne Marie Valente; Elizabeth D Blume; Pedro del Nido
Journal:  Ann Thorac Surg       Date:  2009-08       Impact factor: 4.330

9.  Resolution of plastic bronchitis with atrial pacing in a patient with fontan physiology.

Authors:  B J Barber; G H Burch; D Tripple; S Balaji
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655

10.  Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog.

Authors:  Paul R Houin; Livia A Veress; Raymond C Rancourt; Tara B Hendry-Hofer; Joan E Loader; Jacqueline S Rioux; Rhonda B Garlick; Carl W White
Journal:  Pediatr Pulmonol       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.